Saavedra JMBrain and pituitary angiotensin. Endocr Rev1992;13:329-80.
3.
Bottari SP, de Gasparo M., Steckelings UM, Levens NRAngiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol1993;14:123-71.
4.
Wright JW, Harding JWBrain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev1994;18:21-53.
5.
Semple PF, Boyd AS, Dawes PM, Morton JJAngiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res1976;39:671-8.
6.
Harding J., Yoshida MS, Dilts RP, Woods TM, Wright JWCerebroventricular and intravascular metabolism of [125I]angiotensins in rat . J Neurochem1986;46:1292-7.
7.
Zini S., Fournie-Zaluski MC, Chauvel E., Roques BP, Corvol P., Llorens-Cortes C.Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.Proc Natl Acad Sci USA1996;93:11968-73.
8.
Tonnaer JA, Wiegant VM, de Jong W., De Wied D.Proteolytic conversion of angiotensins in rat brain tissue. Eur J Biochem1983;131:415-21.
9.
Welches WR, Santos RA, Chappell MC, Brosnihan KB, Greene LJ, Ferrario CMEvidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens1991;9:631-8.
10.
Neves LA, Almeida AP, Khosla MC, Santos RAMetabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors. Biochem Pharmacol1995;50:1451-9.
11.
Welches WR, Brosnihan KB, Ferrario CMA comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci1993 ;52:1461-80.
12.
Pendleton RG , Gessner G., Horner E.Studies defining minimal receptor domains for angiotensin II. J Pharmacol Exp Ther1989 ;250:31-6.
13.
Blair-West JR,Coghlan JP, Denton DA, Funder JW, Scoggins BA, Wright RDThe effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocrinol Metab1971;32:575-8.
14.
Fitzsimons JTThe effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol1971;214:295-303.
15.
Caldicott WJ , Taub KJ, Hollenberg NKIdentical mesenteric, femoral and renal vascular responses to angiotensin II and III in the dog . Life Sci1977;20:517-21.
16.
Wright JW, Morseth S., Mana MJ, LaCrosse E., Peterson EP, Harding JWCentral angiotensin III-induced dipsogenicity in rats and gerbils . Brain Res1984;295:121-6.
17.
Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JWIntracerebroventric-ularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Brain Res1990;514:5-10.
18.
Harding JW, Felix D.Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res1987;410:130-4.
19.
Reaux A., de Mota N., Zini S. et al. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology1999;69:370-6.
20.
Zini S., DemasseyY,Fournie-Zaluski MC, et al. Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase Ainhibitor. Neuroreport1998 ;9:825-8.
21.
Reaux A., Fournie-Zaluski MC, David C. et al. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA1999;96:13415-20.
22.
Reaux A., Iturrioz X., Vazeux G. et al. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans2000;28:435-40.
23.
Reaux A., Fournie-Zaluski MC, Llorens-Cortes C.Angiotensin III: a central regulator of vasopressin release and blood pressure . Trends Endocrinol Metab2001;12:157-62.
24.
Ruiz-Ortega M. , Lorenzo O., Egido J.Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts. Kidney Int Suppl1998;68:S41-5.
25.
Ruiz-Ortega M. , Lorenzo O., Egido J.Angiotensin III increases MCP-1 and activates NF-κB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int2000;57:2285-98.
26.
Tonnaer JA, Wiegant VM, de Jong W., De Wied D.Central effects of angiotensins on drinking and blood pressure: structure-activity relationships. Brain Res1982;236:417-28.
27.
Porsti I., BaraAT,Busse R., Hecker M.Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol1994;111:652-4.
28.
Brosnihan KB , Li P., Ferrario CMAngiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension1996;27:523-8.
29.
Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJDifferential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol1993;234:35-42.
30.
Jaiswal N., Tallant EA, Diz DI, Khosla MC, Ferrario CMSubtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes . Hypertension1991;17:1115-20.
31.
Jaiswal N., Diz DI, Tallant EA, Khosla MC, Ferrario CMCharacterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol1991;260:R1000-6.
32.
Jaiswal N., Diz DI, Chappell MC, Khosla MC, Ferrario CMStimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension1992;19:1149-55.
33.
Jaiswal N., Jaiswal RK, Tallant EA, Diz DI, Ferrario CMAlterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension1993 ;21:900-5.
34.
Jaiswal N., Tallant EA, Jaiswal RK, Diz DI, Ferrario CMDifferential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved . J Pharmacol Exp Ther1993;265:664-73.
35.
Oliveira MA , Fortes ZB, Santos RA, Kosla MC, De Carvalho MHSynergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Peptides1999;20:1195-201.
36.
Paula RD et al. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides. Peptides1999;20:493-500.
Deddish PA et al. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension1998;31:912-7.
39.
Yamada K., Iyer SN, Chappell MC, Ganten D., Ferrari, CMConverting enzyme determines plasma clearance of angiotensin-(1-7) . Hypertension1998;32:496-502.
40.
Machado RD, Santos RA,Andrade SPOpposing actions of angiotensins on angiogenesis. Life Sci2000;66:67-76.
41.
Strawn WB, Ferrario CM, Tallant EAAngiotensin-(1-7) reduces smooth muscle growth after vascular injury . Hypertension1999;33:207-11.
Tallant EA, Higson JTAngiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia1997 ;19:333-42.
44.
Freeman EJ, Tallant EAVascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation. Biochem J1994 ;304:543-8.
45.
Freeman EJ, Ferrario CM,Tallant EAAngiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens1995;8:1105-11.
Ferrario CM , Chappell MC, Tallant EA, Brosnihan KB, Diz DICounterregulatory actions of angiotensin-(1-7) . Hypertension1997;30:535-41.
48.
Ferrario CM , Iyer SNAngiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regul Pept1998 ;78:13-18.
49.
Chappell MC , Diz DI, Yunis C., Ferrario CMDifferential actions of angiotensin-(1-7) in the kidney. Kidney Int Suppl1998;68:S3-6.
50.
Tipnis SR, Hooper NM, Hyde R., Karran E., Christie G., Turner AJA human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase. J Biol Chem2000;275:33238-43.
51.
Donoghue M. , Hsieh F., Baronas E. et al.A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res2000;87:E1-9.
52.
de Gasparo M., Husain A., Alexander W. et al. Proposed update of angiotensin receptor nomenclature. Hypertension1995;25:924-7.
53.
Swanson GN, Hanesworth JM, Sardinia MF et al. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept1992;40:409-19.
54.
Harding JW, Cook VI, Miller-Wing AV et al. Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus. Brain Res1992;583:340-3.
55.
Miller-Wing AV, Hanesworth JM, Sardinia MF et al. Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther1993;266:1718-26.
56.
Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JWElucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther1993 ;266:1036-42.
57.
Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL, Harding JWIdentification and characterisation of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept1993;44:225-32.
58.
Hall KL, Venkateswaran S., Hanesworth JM, Schelling ME, Harding JWCharacterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept1995;58:107-15.
59.
Moeller I., Chai SY, Oldfield BJ, McKinley MJ, Casley D., Mendelsohn FALocalization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord and hind-brain. Brain Res1995;701:301-6.
60.
Moeller I., Paxinos G., Mendelsohn FA,Aldred GP, Casley D., Chai SYDistribution of AT4 receptors in the Macaca fascicularis brain. Brain Res1996;712:307-24.
61.
Chai SY, Bastias MA, Clune EF et al. Distribution of angiotensin IV binding sites (AT(4) receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. J Chem Neuroanat2000;20:339-48.
62.
de Gasparo M., Catt KJ, Inagami , T., Wright JW, Unger T.International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev2000;52:415-72.
63.
Braszko JJ, Kupryszewski G., Witczuk B., Wisniewski K.Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience1988;27:777-83.
64.
Wright JW, Miller-Wing AV, Shaffer MJ et al. Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull1993;32:497-502.
65.
Tchekalarova J., Kambourova T., Georgiev V.Interaction between angiotensin IV and adenosine A(1) receptor related drugs in passive avoidance conditioning in rats. Behav Brain Res2001 ;123:113-16.
66.
Delorenzi ALF , Romano A., Nahmod V., Maldonado H.Angiotensin II (3-8) induces long-term memory improvement in the crab Chasmagnathus. Neurosci Lett1997;226:143-6.
67.
Wright JW, Stubley L., Pederson ES, Kramar EA, Hanesworth JM, Harding JWContributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J Neurosci1999;19:3952-61.
68.
Roberts KA, Krebs LT, Kramar EA, Shaffer MJ, Harding JW, Wright JWAutoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res1995;682:13-21.
69.
Lee JCS , Mendelsohn FA, Morris MJ, Allen AMPotentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7 . Neuropharmacology2001;40:618-23.
70.
Kramar EA,Armstrong DL, Ikeda S.,Wayner MJ, Harding JW, Wright JWThe effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res2001;897:114-21.
71.
Wayner Mjad , Phelix CF, Wright JW, Harding JWAngiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides2001;22:1403-14.
Kramar EA, Krishnan R., Harding JW, Wright JWRole of nitric oxide in angiotensin IV-induced increases in cerebral blood flow. Regul Pept1998;74:185-92.
74.
Coleman JK, Lee JI, Miller JM, Nuttall ALChanges in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs. Heart Res1998;119:61-8.
75.
Patel JM, Martens JR, Li YD, Gelband CH, Raizada MR, Block ERAngiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am J Physiol1998;275:L1061-8.
76.
Gardiner SM , Kemp PA, March JE, Bennett T.Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol1993;110:159-62.
77.
Cheng DY, DeWitt BJ, Dent EL, Nossaman BD, Kadowitz PJAnalysis of responses to angiotensin IV in the pulmonary vascular bed of the cat.EurJPharmacol1994;261:223-7.
78.
Nossaman BD , Feng CJ, Kaye AD, Kadowitz PJAnalysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat. AmJPhysiol1995;268:L302-8.
79.
Garrison EA , Santiago JA, Osei SY, Kadowitz PJAnalysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat. AmJPhysiol1995;268:H2418-25.
80.
Li Q., Feenstra M., Pfaffendorf M., Eijsman L., van Zwieten PAComparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.J Cardiovasc Pharmacol1997;29:451-6.
81.
Moeller I., Small DH, Reed G., Harding JW, Mendelsohn FA, Chai SYAngiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Res1996;725:61-6.
82.
Mustafa T., Chai SY, Mendelsohn FA, Moeller I.,AlbistonALCharacterization of the AT(4) receptor in a human neuroblastoma cell line (SK-N-MC).JNeurochem2001;76:1679-87.
83.
Moeller I., Albiston AL, Lew RA, Mendelsohn FA, Chai SYA globin fragment, LVV-hemorphin-7, induces [3H]thymidine incorporation in a neuronal cell line via the AT4 receptor. J Neurochem1999;73:301-8.
84.
Kakinuma Y.Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nature Medicine1998;4: 1078-80.
85.
Kakinuma Y. , Hama H., Sugiyama F., Goto K., Murakami K., Fukamizu A.Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci Lett1997;232:167-70.
86.
Kakinuma Y. , Sugiyama F.,Taniguchi K. et al. Developmental stage-specific involvement of angiotensin in murine nephrogenesis. Pediatr Nephrol1999;13:792-9.
87.
Pawlikowski M., Kunert-Radek J.Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro. Biochem Biophys Res Commun1997;232:292-3.
88.
Wang L., Eberhard M., Erne P.Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci (Lond) 1995;88:557-62.
89.
Pawlikowski M., Melen-Mucha G., Mucha S.The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium. Cell Mol Life Sci1999;55:506-10.
90.
Moeller I., Clune EF, Fennessy PA et al. Up regulation of AT4 receptor levels in carotid arteries following balloon injury. Regul Pept1999;83:25-30.
91.
Zhang JH, Stobb JW, Hanesworth JM, Sardinia MF, Harding JWCharacterization and purification of the bovine adrenal angiotensin IV receptor (AT4) using [125I]benzoylphenylalanine-angiotensin IV as a specific photolabel . J Pharmacol Exp Ther1998;287:416-24.
92.
Zhang JH, Hanesworth JM, Sardinia MF, Alt JS, Wright JW, Harding JWStructural analysis of angiotensin IV receptor (AT4) from selected bovine tissues. J Pharmacol Exp Ther1999;289:1075-83.
93.
Bernier SG, Bellemare JM, Escher E., Guillemette G.Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV. Biochemistry1998;37:4280-7.
94.
Yang Q., Hanesworth JM, Harding JW, Slinker BKThe AT4 receptor agonist [Nle]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart. Regul Pept1997;71:175-83.
95.
Kerins DM, Hao Q.,Vaughan DEAngiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest1995;96:2515-20.
96.
Gesualdo L. , Ranieri E., Monno R. et al.Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int1999;56:461-70.
97.
Skurk T., Lee YM, Rohrig K., Hauner H.Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes. Horm Metab Res2001;33:196-200.
98.
Skurk T., Lee YM, Hauner H.Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension2001;37:1336-40.
99.
Nishimura H. , Tsuji H., Masuda H. et al. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost1999;82:1516-21.
100.
Chen HC, Bouchie JL, Perez AS et al. Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression. Arterioscler Thromb Vasc Biol2000;20:2297-302.
101.
Ransom JT, Sharif NA, Dunne JF, Momiyama M., Melching G.AT1 Angiotensin Receptors Mobilize Intracellular Calcium in a Subclone of NG 108-15 Neuroblastoma Cells. J Neurochem1992;58:1883-8.
102.
Baker MF, Aceto FJAngiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol1990;259:H610-H618.
103.
Dostal DE, Murahashi T., Peach MJRegulation of cytosolic calcium by angiotensins in vascular smooth muscle . Hypertension1990;15:815-22.
104.
Dulin N., Madhun ZT, Chang CH, Berti-Mattera L., Dickens D., Douglas JGAngiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol1995;269:F644-52.
105.
Chansel D. , Vandermeersch S., Oko A., Curat C., Ardaillou R.Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells. Eur J Pharmacol2001;414:165-75.
106.
Chen JK, Zimpelmann J., Harris RC, Burns KDAngiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol Renal Physiol2001;280:F980-8.
107.
Handa RK, Harding JW, Simasko SMCharacterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. J Pharmacol Exp Ther1999;291:1242-9.
108.
Patel JM, Li YD, Zhang J., Gelband CH, Raizada MK, Block ERIncreased expression of calreticulin is linked to ANG IVmediated activation of lung endothelial NOS. Am J Physiol1999 ;277:L794-801.
109.
Moeller I. , Lew RA, Mendelsohn FA et al.The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain . J Neurochem1997;68:2530-7.
110.
Chang RC, Huang WY, Redding TW, Arimura A., Coy DH, Schally AVIsolation and structure of several peptides from porcine hypothalami . Biochim Biophys Acta1980:625:266-73.
111.
Barkhudaryan N., Kellermann J., Galoyan A., Lottspeich F.High molecular weight aspartic endopeptidase generates a coronaro-constrictory peptide from the beta-chain of hemoglobin . FEBS Lett1993 ;329:215-18.
112.
Glamsta EL , MarklundA,Hellman U.,Wernstedt C.,Terenius L., Nyberg F.Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland. Regul Pept1991;34:169-79.
113.
Karelin AA , Philippova MM, Karelina EV, Ivanov VTIsolation of endogenous hemorphin-related hemoglobin fragments from bovine brain. Biochem Biophys Res Commun1994;202:410-15.
114.
Piot JM, Zhao Q., Guillochon D., Ricart G., Thomas D.Isolation and characterization of two opioid peptides from a bovine hemoglobin peptic hydrolysate. Biochem Biophys Res Commun1992;189:101-10.
115.
Fitzgerald SM, Evans RG, Bergstrom G., Anderson WPRenal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats. J Cardiovasc Pharmacol1999;34:206-11.